Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

NASDAQ:DYN

Overview | Financials
Company Name Dyne Therapeutics, Inc.
Symbol DYN
Currency USD
Price 15.54
Market Cap 1,581,443,640
Dividend Yield 0%
52-week-range 14.792 - 47.45
Industry Biotechnology
Sector Healthcare
CEO Mr. Joshua T. Brumm
Website https://www.dyne-tx.com

An error occurred while fetching data.

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and

Related Stocks

Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc.

LXRX

0.728 USD

AlloVir, Inc. logo

AlloVir, Inc.

ALVR

0.381 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.255 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

5.04 USD

Financials

Numbers are in millions USD

Numbers are in millions USD